These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 1016972)
21. [Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma]. Beretta G; Bajetta E; Bonadonna G; Tancini G; Orefice S; Veronesi U Tumori; 1973; 59(3):239-48. PubMed ID: 4729646 [No Abstract] [Full Text] [Related]
22. [Photosensitization with DTIC therapy in metastatic malignant melanoma]. Bolling R; Meyer-Hamme S; Schauder S Hautarzt; 1980 Nov; 31(11):602-5. PubMed ID: 7451142 [TBL] [Abstract][Full Text] [Related]
23. [Results with new cytotoxic agents]. Brufman G; Biran S; Ratzkowski E Harefuah; 1976 Nov; 91(9):268-70. PubMed ID: 1010474 [No Abstract] [Full Text] [Related]
24. Combination chemotherapy with bis chloroethyl nitrosourea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanoma. McKelvey EM; Luce JK; Talley RW; Hersh EM; Hewlett JS; Moon TE Cancer; 1977 Jan; 39(1):1-4. PubMed ID: 832224 [TBL] [Abstract][Full Text] [Related]
25. [Treatment of advanced malignant melanoma with DTIC]. Jassem J; Kopacz A; Wojszwiłło-Geppert E Pol Tyg Lek; 1979 Feb; 34(8):293-5. PubMed ID: 441041 [No Abstract] [Full Text] [Related]
26. [Comparison of the efficacy of imidazole-carboxamide and of a combination of nitrosomethylurea, vincristine and dactinomycin in disseminated melanoma]. Kogoniia LM; Moroz LV; Perevodchikova NI; Platinskiĭ LV; Borisov AI Vopr Onkol; 1981; 27(4):16-21. PubMed ID: 7015692 [TBL] [Abstract][Full Text] [Related]
27. Comparative evaluation of three combination regimens for advanced malignant melanoma: results of an international cooperative study. Beretta G; Bonadonna G; Cascinelli N; Morabito A; Veronesi U Cancer Treat Rep; 1976 Jan; 60(1):33-40. PubMed ID: 1000518 [TBL] [Abstract][Full Text] [Related]
28. Combined DTIC and cis-dichlorodiammineplatinum(II) therapy for patients with disseminated melanoma: a Northern California Oncology Group study. Friedman MA; Kaufman DA; Williams JE; Resser KJ; Rosenbaum EH; Cohen RJ; Glassberg AB; Blume MR; Gershow J; Chan EY Cancer Treat Rep; 1979 Mar; 63(3):493-5. PubMed ID: 371802 [No Abstract] [Full Text] [Related]
29. Phase I--II study of intermittent bolus administration of DTIC and actinomycin D in metastatic malignant melanoma. Samson MK; Baker LH; Talley RW; Fraile RJ; McDonald B Cancer Treat Rep; 1978 Aug; 62(8):1223-5. PubMed ID: 356980 [TBL] [Abstract][Full Text] [Related]
30. Use of combination chemotherapy with CCNU, bleomycin, and vincristine in the treatment of metastatic melanoma in patients resistant to DTIC therapy. Everall JD; Dowd PM Cancer Treat Rep; 1979 Jan; 63(1):151-5. PubMed ID: 84710 [No Abstract] [Full Text] [Related]
31. Phase II study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanoma. Ahmann DL; Edmonson JH; Frytak S; Kvols LK; Bisel HF; Rubin J Cancer Treat Rep; 1978 Jan; 62(1):151-3. PubMed ID: 626995 [No Abstract] [Full Text] [Related]